Bionet, Taiwan

Last updated: 13.02.2014

bionet-logo-1.jpgOrganization Activities

BIONET Corp. was first established in 1999 as the pioneer company in the field of stem cell application in Taiwan as well as in Asia. BIONET has focused: “Stem Cell Therapy” and “Genetic Testing”. In 2007, BIONET completed initial public offering (TPO: 1784) and became the first publicly traded company in the stem cell and genetic industry of Taiwan. Furthermore, in 2012, Genesis Genetics Asia Corp. (GGA), a subsidiary of BIONET, made its IPO (TPO: 4160) as Taiwan’s first public company specialized in both genetic testing and scientific informatics. BIONET is the largest enterprise that the penetration rate is up to 50% for cell therapy and genetic engineering industry in Taiwan.

Contact Information

Address: No.28, 36 Ln., Xinhu 1st Rd., 
Neihu Dist., Taipei City 11494 

Phone: +886-2-2795-1777, Monday to Friday, 9am-6pm CST (UTC+8)
Toll-free: 0800-800-018




We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here